Bodytechmed Obtains Domestic Approval for COVID-19 and Influenza Virus Dual Diagnostic Kit

Bodytechmed COVID-19 and Influenza Simultaneous Diagnostic Kit 'ichroma™ COVID-19 Ag&Flu A+B' [Photo by Bodytechmed]

[Asia Economy Reporter Lee Gwan-joo] Bodytech Med announced on the 3rd that it has obtained domestic approval from the Ministry of Food and Drug Safety for the diagnostic kit 'ichroma™ COVID-19 Ag/Flu A+B,' which can simultaneously diagnose COVID-19 and influenza.

This product combines the previously approved COVID-19 diagnostic kit and a kit that detects influenza A and B virus infections into one set, allowing users to check for COVID-19 and influenza infections at the same time.

Users can collect specimens from nasopharyngeal swabs and nasal aspirates, then apply the specimens to each of the two kits to confirm infection status. The testing time is 12 minutes for COVID-19 and 10 minutes for influenza.

Choi Eui-yeol, CEO of Bodytech Med, said, "As COVID-19 shows signs of resurgence, the number of patients visiting hospitals suspected of influenza virus infection is also increasing, raising concerns about the realization of a 'twindemic' this winter. We expect high demand for diagnostic kits that can simultaneously detect both viruses in medical settings, so we will accelerate the supply of the COVID-19 and influenza simultaneous diagnostic kit."

This content was produced with the assistance of AI translation services.